Risk acceptance in multiple sclerosis patients on natalizumab treatment. Tur C, Tintoré M, Vidal-Jordana A, Bichuetti D, Nieto González P, Arévalo M J, Arrambide G, Anglada E, Galán I, Castilló J, et al. PLoS One. 2013; 8(12):e82796. Epub 2013 Dec 10. PMID: 24340060. Abstract CommentRecommendBookmarkWatch